Galectin Therapeutics Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: -1.04x
Net debt / equity: -0.93x
Debt / assets: 8.61x
Debt / EBITDA: -7.29x
Net debt / EBITDA: -6.53x

Liquidity & coverage

Current ratio: 2.15x
Quick ratio: 2.15x
Cash ratio: 1.93x
Interest coverage: -2.15x
EBITDA / interest: -2.46x
Working capital: $8.4M

Cash & dividend

FCF / debt: -0.15x
Cash flow / debt: -0.15x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.